Actinium Pharmaceuticals
ATNM
ATNM
69 hedge funds and large institutions have $13.2M invested in Actinium Pharmaceuticals in 2025 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 24 increasing their positions, 17 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
0.21% more ownership
Funds ownership: 26.07% → 26.28% (+0.21%)
0% more funds holding
Funds holding: 69 → 69 (0)
Holders
69
Holding in Top 10
–
Calls
$129K
Puts
$10K
Top Buyers
| 1 | +$495K | |
| 2 | +$365K | |
| 3 | +$227K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$121K |
| 5 |
AQR Capital Management
Greenwich,
Connecticut
|
+$74.9K |
Top Sellers
| 1 | -$242K | |
| 2 | -$231K | |
| 3 | -$214K | |
| 4 |
JPMorgan Chase & Co
New York
|
-$165K |
| 5 |
Millennium Management
New York
|
-$148K |
